Gel preparation for oral administration

Details Gel preparation for oral administration Gel preparation for oral administration

A - Human Necessities

61

K

A61K 31/47 (2006.01) A61K 31/22 (2006.01) A61K 31/366 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 47/32 (2006.01) A61K 47/36 (2006.01) A61K 47/38 (2006.01)

Patent

CA 2619367

Provided for use in medical care settings is a gel preparation for oral administration to patients with hyperlipemia or hypercholesterolemia, wherein the ingestibility of an HMG-CoA reductase inhibitor, also known as a statin-series compound, has been improved in dosage forms of tablets, granules and liquids. A pharmaceutical composition in a gel form, comprising an HMG-CoA reductase inhibitor or a pharmaceutically acceptable salt thereof, a gelling agent, a polymer compound, a buffering agent, a preservative, a sweetening agent, a base and water, wherein the bad tastes of the statin-series compound are disguised, syneresis during storage is less likely, form retention is good, removal from containers is easy, and the ingestibility has been improved.

Affiliated with

Also associated with

Rating

Gel preparation for oral administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gel preparation for oral administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gel preparation for oral administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1881987